AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL)

CUSIP: G29687103

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Ordinary Shares, nominal value $0.01 per share
Shares outstanding
95,992,895
Total 13F shares
79,038,211
Share change
-1,910,679
Total reported value
$1,206,765,098
Put/Call ratio
61%
Price per share
$15.27
Number of holders
183
Value change
-$19,096,496
Number of buys
92
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP G29687103?
CUSIP G29687103 identifies AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) as of Q3 2025

As of 30 Sep 2025, AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) was held by 183 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,038,211 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, BlackRock, Inc., VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, Two Seas Capital LP, GENDELL JEFFREY L, Polar Capital Holdings Plc, Vivo Capital, LLC, STATE STREET CORP, and WEALTH EFFECTS LLC. This page lists 183 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.